Know More About
NAYAS LABS
Take a Closer Look
Nayas Laboratories Private Limited ("Nayas"), established in the year 2023, is India's Promising Contract Research Organization specializing in the development of Novel, Innovative, Patentable Biomedical Polymers, advanced Drug Delivery Technology Platforms and Formulations.
Nayas is also one of the fastest growing independent Drug Delivery & Formulation Research and Development Services organization with primary focus on Drug Delivery Technologies, Complex Generics, 505(b)(2), Complex Injectables, Topicals, Orals and Sterile Formulations.
Nayas is a subsidiary of Jeevan Scientific Technology Limited, a public limited company listed in Bombay Stock Exchange (BSE). JSTL offers services in the areas of BA/BE, Clinical Trials and Pharmacovigilance.
Nayas is Quality Driven Organization that is fully equipped with state-of-the-art facilities and robust technologies to develop quality and robust formulations/ globally accepted dossiers for various dosage forms.
To provide first-rate, robust, customer-centric and exceptional Drug Delivery Systems, Formulation Services and Pharmaceutical Polymers of a superior nature to prevent, alleviate and cure diseases.
A one stop shop for all your formulation needs and carry the Vision to be the most respected, promising, qualitative and advanced formulation research and development center.
Nayas aims to enhance its expert and innovative solutions by best use of cutting-edge technology, rich expertise, world-class research and Development and its highest Qualitative approach.
Our Differentiation
1
Polymer
Polymer Selection, R&D, Manufacturing
2
FEW
Proof of Concept Development
3
Formulation
Complete Formulation Development
4
Scale-Up
Scale-up support to CMO
5
Clinicals
BA/BE, Clinical Trials
6
Case
Regulatory Support
About Jeevan Scientific Technology Limited
(Our Parent Company)
Jeevan Scientific Technology Limited (JSTL), is an independent Clinical Research Services Organization providing services in the areas of BA/BE, Clinical Trials and Pharmacovigilance. JSTL was established in the year 1999 and operates as a public limited company listed in Bombay Stock Exchange (BSE). The Regulatory Inspection history of JSTL includes US-FDA, UK-MHRA, WHO, Oman, CDSCO, NABL etc.
JSTL has state-of-the-art facilities including 156 Bed Clinical Facility, 17 LC-MS/MS machines (API 6500+, API 4500, API 4000, Shimadzu 8050), Elisa, Biomedical Freezers, Cold Walk-in Chamber, Central Archival etc.
Visit www.jeevanscientific.com to know more.